JW
NRXP icon

Jenkins Wealth’s NRX Pharmaceuticals NRXP Stock Holding History

Jenkins Wealth’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$15.7K Buy
+1,418
New +$14.3K 0.01% 76

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Jenkins Wealth's NRXP Position: Q4 2022 in Review

Jenkins Wealth opened a new position in NRX Pharmaceuticals (NRXP) in Q4 2022: 1,418 shares worth $15.7K. The stake represents 0.01% of the portfolio and ranks #76 among its holdings.

33 funds tracked by Wall St. Rank hold NRXP as of Q4 2022.

  • Jenkins Wealth held 1,418 shares of NRX Pharmaceuticals worth $15.7K as of Q4 2022.
  • NRX Pharmaceuticals was a new Jenkins Wealth position in Q4 2022.
  • NRX Pharmaceuticals made up 0.01% of Jenkins Wealth's portfolio in Q4 2022, its #76 holding.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2022.

Based on Jenkins Wealth's 13F filing for Q4 2022, filed 11 Jan 2023.